Ultrathin gallium nitride quantum‑disk‑in‑nanowire‑enabled reconfigurable bioinspired sensor for high‑accuracy human action recognition
2025-11-13
(Press-News.org)
As artificial vision systems evolve, bridging the gap between sensing and processing remains a key challenge. Now, researchers from the University of Science and Technology of China, led by Prof. Yong Yan and Prof. Haiding Sun, have developed a reconfigurable bioinspired vision sensor using GaN/AlN quantum-disk-in-nanowires (QD-NWs) that emulates the human retina’s dual-cell system—delivering in-sensor computing for high-accuracy human action recognition (HAR).
Why This Bioinspired Sensor Matters
Dual-Mode Operation: Mimics Parvo cells (slow, high-contrast vision) and Magno cells (fast, motion-sensitive vision) via voltage-tunable persistent photocurrent (PPC).
In-Sensor Computing: Combines image enhancement and reservoir computing in a single device, reducing latency and power consumption.
High Accuracy: Boosts HAR accuracy from 51.4% to 81.4% through synergistic integration of both photoresponse modes.
Innovative Design and Features
Quantum-Confined Stark Effect (QCSE): Enables bias-tunable control over carrier recombination, switching between long-term and short-term PPC.
Nanowire Architecture: Ultrathin GaN/AlN QD-NWs grown on Si substrates offer CMOS compatibility, strain relaxation, and strong optoelectronic tunability.
Reservoir Computing System: Uses short-term PPC for temporal feature extraction and long-term PPC for image denoising and enhancement.
Applications and Performance
Image Enhancement: Under negative bias, the sensor enhances image contrast in real time—improving SNR from 1/0.3 to 1/0.15 without external processing.
Human Action Recognition: Under positive bias, the sensor acts as a hardware-based reservoir, classifying 10 human actions from the Weizmann dataset with >95% accuracy.
Robustness: Maintains >90% recognition accuracy even under 50% device noise, outperforming software-only approaches.
Conclusion and Outlook
This work introduces a compact, intelligent vision sensor that unites biological inspiration with semiconductor engineering, enabling real-time, low-power, high-accuracy visual perception. The QD-NW platform opens new pathways for neuromorphic vision systems, edge AI, and smart surveillance applications.
Stay tuned for more breakthroughs from Prof. Yong Yan and Prof. Haiding Sun’s team at USTC!
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-11-13
Nuclear fusion, which operates on the same principle that powers the Sun, is expected to become a sustainable energy source for the future. To achieve fusion power generation, it is essential to confine plasma at temperatures exceeding one hundred million degrees using a magnetic field and to maintain this high-energy state stably. A key factor in accomplishing this is the electric potential inside the plasma. This potential governs the transport of particles and energy within the plasma and plays a crucial role in establishing a state in which energy is effectively confined and prevented ...
2025-11-13
CHAMPAIGN, Ill. — A naturally occurring protein that tends to be expressed at higher levels in breast cancer cells boosts the effectiveness of some anticancer agents, including doxorubicin, one of the most widely used chemotherapies, and a preclinical drug known as ErSO, researchers report. The protein, FGD3, contributes to the rupture of cancer cells disrupted by these drugs, boosting their effectiveness and enhancing anticancer immunotherapies.
The discovery is described in the Journal of Experimental & Clinical Cancer Research.
The new findings were the happy result of experiments involving ErSO, an experimental drug that killed 95-100% of estrogen-receptor-positive ...
2025-11-13
A widely-used, inexpensive gout drug could reduce heart attacks and strokes in people with cardiovascular disease, according to a new Cochrane review.
The review examined the effects of low doses of colchicine, a drug used to treat gout, and found no increase in serious side effects.
Cardiovascular disease is often driven by chronic low-grade inflammation, which contributes to recurrent cardiovascular events such as heart attacks and strokes. Colchicine has anti-inflammatory properties that make it a promising option for people with heart disease.
A promising effect on cardiovascular risk
The review included 12 randomized controlled trials involving nearly 23,000 ...
2025-11-13
EMBARGOED: Hold for release until Wednesday, Nov. 12 at 18:30 ET / 23:30 UK time
Headache disorders affect 3 billion people worldwide—nearly one in every three people, ranking sixth for health loss in 2023
Women experienced more than twice the headache-related health loss of men and spent a greater share of their lives with headache symptoms.
Migraine caused nearly 90% of all disability linked to headache disorders, even though tension-type headache was more common.
More than one-fifth of the global headache burden ...
2025-11-13
ROCHESTER, Minn. — Mayo Clinic researchers have developed a new tool that can estimate a person's risk of developing memory and thinking problems associated with Alzheimer's disease years before symptoms appear. The research, published in The Lancet Neurology, builds on decades of data from the Mayo Clinic Study of Aging — one of the world's most comprehensive population-based studies of brain health.
The study found that women have a higher lifetime risk than men of developing dementia and mild cognitive impairment (MCI), a transitional stage between healthy aging and dementia ...
2025-11-13
Extending anti-clotting drugs beyond the initial treatment period of at least 90 days after a first blood clot is linked to lower rates of new clots developing compared with stopping treatment, finds a US study published by The BMJ today.
Extended treatment was also linked to higher rates of major bleeding (a common side effect of anti-clotting drugs) but the authors say continued use results in an overall “net clinical benefit.”
Guidelines recommend anti-clotting treatment for at least 3-6 months for patients with venous thromboembolism ...
2025-11-13
Exposing children to e-cigarettes compromises their human rights. These products should be regulated in a way that puts children’s best interests first and protects them from the harms associated with nicotine consumption in all its forms, argue experts in The BMJ today.
Children are now using e-cigarettes at higher rates than adults, write Tom Gatehouse and colleagues. Globally, the World Health Organization (WHO) estimates that 7.2% of children aged 13-15 currently use e-cigarettes. Data indicate use in this group is nine times that of adults, in countries which monitor both groups.
As ...
2025-11-13
The rate of high blood pressure (hypertension) in children and adolescents under 19 has nearly doubled, increasing from about 3% in 2000 to over 6% in 2020.
More than 9% of children and adolescents have masked hypertension — high blood pressure that only shows up with out-of-office tests, meaning hypertension could be undetected during regular checkups.
Nearly 19% of children and adolescents with obesity have hypertension, eight times higher than the prevalence of hypertension in those considered a healthy weight.
Approximately 8% of children and adolescents now have prehypertension, a warning sign of potential progression to hypertension, which ...
2025-11-13
Seattle, United States & Seoul, Republic of Korea—PATH and EuBiologics Co., LTD are pleased to announce Phase 3 results from a clinical trial of a typhoid conjugate vaccine (TCV), EuTYPH-C Inj.® Multi-dose. EuTYPH-C Inj.® Multi-dose is manufactured by EuBiologics Co., LTD, Republic of Korea. The results, published in The Lancet Global Health, demonstrate that EuTYPH-C Inj.® Multi-dose is safe and immunogenic in typhoid-endemic populations in sub-Saharan Africa.
The study was conducted at sites in Kenya and Senegal in healthy ...
2025-11-13
Global carbon emissions from fossil fuels are projected to rise by 1.1% in 2025 – reaching a record high, according to new research by the Global Carbon Project.
The 2025 Global Carbon Budget projects 38.1 billion tonnes of fossil carbon dioxide (CO2) emissions this year.
Decarbonisation of energy systems is progressing in many countries – but this is not enough to offset the growth in global energy demand.
With projected emissions from land-use change (such as deforestation) down to 4.1 billion ...
LAST 30 PRESS RELEASES:
[Press-News.org] Ultrathin gallium nitride quantum‑disk‑in‑nanowire‑enabled reconfigurable bioinspired sensor for high‑accuracy human action recognition
